Skip to main content
. 2021 Jul 3;19:288. doi: 10.1186/s12967-021-02942-y

Fig. 5.

Fig. 5

Validation of the nomogram in the validation set. A Distribution of the risk scores calculated by the nomogram scoring system. B Patient distribution in the low- and high-score groups based on progression status. C Progression-free survival curves stratified by the low- and high-score groups. D Time-dependent ROC curves for nomogram vs. other single parameters included in the model